Skip to main content
Signal8

Waheed Nadia

SEC insider (Form 3/4/5 filer). CIK 0002023884. Chief Medical Officer at OCULAR THERAPEUTIX, INC (OCUL). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in BEDFORD, MA.

Companies Waheed Nadia has filed insider reports for

  • OCULAR THERAPEUTIX, INC (OCUL): Officer, Chief Medical Officer
Waheed Nadia profile photo

Waheed Nadia

CIK: 0002023884

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OCULAR THERAPEUTIX, INC logo
OCUL

OCULAR THERAPEUTIX, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Jun 3, 2026
    Sale
    Direct
    14.8K shares at avg. $8.27$123K
  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Feb 20, 2026
    Sale
    Direct
    3.5K shares at avg. $7.74$27K
  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Feb 12, 2026
    Sale
    Direct
    7.9K shares at avg. $9.04$71K
  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Jan 2, 2026
    Award
    Direct
    79.1K shares-
  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Aug 12, 2025
    Award
    Direct
    40.4K shares-
  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Jun 2, 2025
    Sale
    Direct
    13.9K shares at avg. $8.05$112K
  • OCULAR THERAPEUTIX, INC logo
    OCUL

    OCULAR THERAPEUTIX, INC

    Feb 11, 2025
    Award
    Direct
    79K shares-

1-7 of 7